Showing results (151-160 of 203) with videos related to
Sort By:
Pageof 21
Annals of the New York Academy of Sciences|August 21, 2012
Phenotypic and functional heterogeneity of human bone marrow- and amnion-derived MSC subsetsKavitha Sivasubramaniyan, Daniela Lehnen, Roshanak Ghazanfari, et al.International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 1, 2013
SOX2 expression and prognostic significance in ovarian carcinomaDeborah L Pham, Veit Scheble, Petra Bareiss, et al.Haematologica|April 12, 2012
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II studyBirgit Federmann, Martin Bornhauser, Christoph Meisner, et al.Blood|July 4, 2015
The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell-based immunotherapySimon Walz, Juliane S Stickel, Daniel Johannes Kowalewski, et al.Blood|April 28, 2010
Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemiaFelicitas Thol, Frederik Damm, Katharina Wagner, et al.Oncoimmunology|July 29, 2016
Long-term survival correlates with immunological responses in renal cell carcinoma patients treated with mRNA-based immunotherapySusanne M Rittig, Maik Haentschel, Katrin J Weimer, et al.Blood|September 30, 2006
Hypusination of eukaryotic initiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approachStefan Balabanov, Artur Gontarewicz, Patrick Ziegler, et al.Blood|December 11, 2012
Steady-state neutrophil homeostasis is dependent on TLR4/TRIF signalingStefanie Bugl, Stefan Wirths, Markus P Radsak, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2011
Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemiaFelicitas Thol, Frederik Damm, Andrea Lüdeking, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 30, 2010
Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patientsSusanne M Rittig, Maik Haentschel, Katrin J Weimer, et al.Pageof 21